SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-21-001278
Filing Date
2021-04-29
Accepted
2021-04-29 06:07:50
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS uthr3845831-defa14a.htm DEFA14A 40671
2 GRAPHIC uthr3845831-defa14alogo.jpg GRAPHIC 12382
3 GRAPHIC uthr3845831-defa14ax1x2.jpg GRAPHIC 34485
4 GRAPHIC uthr3845831-defa14ax1x3.jpg GRAPHIC 5212
5 GRAPHIC uthr3845831-defa14ax1x4.jpg GRAPHIC 4549
6 GRAPHIC uthr3845831-defa14ax1x5.jpg GRAPHIC 4754
7 GRAPHIC uthr3845831-defa14ax1x6.jpg GRAPHIC 5663
8 GRAPHIC uthr3845831-defa14ax2x2.jpg GRAPHIC 1141
  Complete submission text file 0001206774-21-001278.txt   136794
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26301 | Film No.: 21866895
SIC: 2834 Pharmaceutical Preparations